Oral phosphate binders: history and prospects

Area of Science:

• Nephrology
• Cardiovascular Medicine
• Pharmacology

Background:

• Vascular calcification is a significant complication in chronic kidney disease (CKD).
• Oral phosphate binders are crucial for managing hyperphosphatemia and preventing vascular calcification in CKD patients.
• Ensuring the safety and efficacy of oral phosphate binders is paramount.

Purpose of the Study:

• To review the safety and efficacy profiles of various oral phosphate binders.
• To identify ideal characteristics for oral phosphate binders in CKD management.
• To discuss the clinical implications of different binder types.

Main Methods:

• Review of existing literature on oral phosphate binders.
• Analysis of safety data (gastrointestinal effects, absorption, organ toxicity).
• Comparison of efficacy and clinical outcomes across different binder classes.

Main Results:

• Metal salt binders (aluminum, lanthanum) are effective but carry risks of accumulation and intoxication.
• Calcium salt binders, while widely used, raise concerns about vascular calcification progression, though recent data show comparable outcomes to non-calcium binders.
• Polymerized resin binders offer a safe and effective option, with constipation being a notable side effect.

Conclusions:

• Oral phosphate binders are essential for CKD patients to prevent vascular calcification.
• Binder selection requires careful consideration of safety profiles, including gastrointestinal tolerance, absorption, and potential toxicity.
• Ongoing research into novel compounds like boehmite and hydrotalcite-like substances may offer future therapeutic advancements.